NeoGenesis
- Company typePrivate
- Founded2012
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What NeoGenesis does
NeoGenesis Co., Ltd. is a South Korea-based private medical device and aesthetics company founded in October 2012 and headquartered in Seoul. The company is positioned as a global leader in autologous cell therapy, with a product portfolio organized across four categories: cell therapy devices (UNISTATION stem cell isolator, LUNA-STEM cell counter, CENTRIFUGE Series, PRP Kit Series, Plasma Gel), aesthetic products (Regenovue HA dermal fillers in multiple variants, Regenovue PN skin booster, NEO THREADS lifting threads in PDO/PCL/PLLA, NEOTOX botulinum toxin, Neome liquid PCL collagen stimulator, NeoFill PLLA collagen stimulator, Aquamate and LeFil mesotherapy injectors), pharmaceuticals (NEO-CAIN CREAM and NEO PRO CREAM topical anesthetics), and cosmetics (BETA SERIES beta-glucan mask and serum, RIOX carboxy CO2 mask). UNISTATION is marketed as the first compact all-in-one stem cell isolation device, and Neome received MDD CE and UKCA approvals in 2025.
The business operates on a B2B, quotation-based pricing model with no public price list; customers reach the company through direct inquiry, website contact, or the global distribution network. Go-to-market is event-driven, anchored by participation in 20+ international medical and aesthetic exhibitions annually (including KIMES Seoul, IMCAS Paris, Cosmoprof, Dubai Derma, Guangzhou CIBE), supported by 6 specialized multilingual sales teams (Korean, English, Chinese, Arabic, Russian). Distribution is executed through 4 wholly-owned overseas branches (USA established 2014, China 2013, Thailand 2013, Taiwan 2013) combined with exclusive regional distributors (e.g., AKSDERMA in Russia, KIN Aesthetics in USA, Polymedical in Azerbaijan), reaching 100+ countries across all 6 continents. The company holds CE, MDD CE, MDR, and UKCA certifications across multiple flagship product lines.
Revenue mechanics combine one-time hardware sales (cell therapy devices, injectors) with recurring consumable purchases (PRP kits, filler syringes, threads, topical anesthetics, skincare), supported by a re-purchase ecosystem where each device installation creates ongoing consumable pull. Export volume milestones have been externally validated by Korean Trade Day Export Awards: $3M (2019), $7M (2021), $10M+ (2023). The company is privately held with no disclosed institutional investors and is led by CEO Yongpil Kim.
NeoGenesis firmographics
Firmographics- Name
- NeoGenesis
- Legal name
- NeoGenesis Co., Ltd.
- Website
- https://neogenesis.co.kr
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
NeoGenesis industry classification
Industry- Product category
- Autologous Cell Therapy Medical Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (33911), Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermatology Specialty Pharmaceuticals (HLAIACAL)
Keywords
Where NeoGenesis is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices5 records
Markets served
NeoGenesis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales: Sale of autologous cell therapy devices including UNISTATION stem cell isolators, centrifuge systems, and mesotherapy injectors. One-time hardware sales with potential for consumable repeat purchases.
- Aesthetic Product Sales: Sale of aesthetic medical products including dermal fillers (Regenovue, NEOFILL), thread lifts (NEO THREADS), botulinum toxin (NEOTOX), and skincare products (BETA SERIES, RIOX masks). Consumable and repeat-purchase products.
- PRP and Cell Therapy Products: Sale of PRP kits, activators, plasma gel makers, and related cell therapy consumables. Recurring revenue from consumable products used with devices.
- Pharmaceuticals: Sale of pharmaceutical products including NEOTOX (botulinum toxin) and topical anesthetics (NEO-CAIN CREAM, NEO PRO CREAM).
- Cosmetics: Sale of post-procedure skincare and cosmetic products including masks, serums, and topical treatments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B quotation-based pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
NeoGenesis product offering
Product offeringCore offering
NeoGenesis Co., Ltd. manufactures and globally distributes autologous cell therapy medical devices (stem cell isolators, centrifuges, PRP kits, plasma gel makers) and aesthetic medical products (HA dermal fillers, botulinum toxin, lifting threads, collagen stimulators, mesotherapy injectors). The company also sells pharmaceutical topical anesthetic creams and post-procedure cosmetic products. Sales are conducted B2B through direct inquiry, four overseas branches, and exclusive regional distributors serving 100+ countries.
Product overview
NeoGenesis is a global leader in autologous cell therapy medical devices, operating as a diversified medical healthcare and aesthetics company. The product portfolio centers on four main categories: Cell Therapy (including UNISTATION stem cell isolator, CENTRIFUGE SERIES, PRP KIT SERIES, and PLASMA GEL), Aesthetics (comprising REGENOVUE HA dermal fillers in multiple variants including GLAM and AQUA SHINE, Regenovue PN skin booster, NEOTOX botulinum toxin, NEO THREADS lifting threads, NEOME and NEOFILL collagen stimulators, and mesotherapy injectors AQUAMATE and LEFIL INJECTOR), Pharmaceuticals (local anesthetic creams NEO-CAIN CREAM and NEO PRO CREAM), and Cosmetics (BETA SERIES beta-glucan products and RIOX carboxy CO2 mask). Supporting accessories include NEO FILLER CANNULA blunt tip needles, NEO NANO NEEDLE micro needles, and SPOTLESS skin blemish remover. The company exports to 100+ countries across 6 continents with regional teams and subsidiaries in USA, China, Thailand, and Taiwan.
Differentiator
Problem solved
Functional benefit
Brands
- UNISTATION: Stem Cell Isolator
- NEO THREADS
- NEOTOX
- BETA SERIES
- LUNA-STEM
- REGENOVUE
- NEO-CAIN CREAM
- RIOX
- NEO PRO CREAM
- PRP KIT SERIES
- Regenovue GLAM
- PRP ACTIVATOR
- Regenovue AQUA SHINE
- CENTRIFUGE SERIES
- Regenovue PN
- PLASMA GEL
- NEOME
- NEOFILL
- AQUAMATE
- LEFIL INJECTOR
- SPOTLESS
- NEO FILLER CANNULA
- NEO NANO NEEDLE
Products and services
- UNISTATION Compact all-in-one stem cell isolation device used in autologous cell therapy treatments. For medical aesthetic clinics and cell therapy centers.
- NEO THREADS Lifting threads for non-surgical facelift procedures, available in PDO/PCL/PLLA materials. For medical aesthetic practitioners.
- NEOTOX Botulinum toxin product for wrinkle reduction and aesthetic treatments. For medical aesthetic clinics.
- BETA SERIES Beta-Glucan mask and serum for skin healing and anti-aging applications. For post-procedure skincare by clinics and end users.
- LUNA-STEM Stem cell counter for automated counting and analysis of stem cells in cell therapy workflows.
- REGENOVUE HA (hyaluronic acid) dermal filler series for facial volume restoration and wrinkle correction, available in multiple formulations including lidocaine variants. CE certified. For medical aesthetic clinics.
- NEO-CAIN CREAM Topical local anesthetic cream for pain management during aesthetic procedures.
- RIOX MASK Carboxy CO2 mask for skin rejuvenation through carboxytherapy.
- NEO PRO CREAM Topical local anesthetic cream for procedural pain relief during aesthetic treatments.
- PRP KIT SERIES Concentrated platelet extractor kits for PRP (Platelet-Rich Plasma) therapy preparations. Recurring consumable products used with devices.
- Regenovue GLAM HA dermal filler variant for body contouring and enhancement procedures.
- PRP ACTIVATOR Platelet growth-hormone stimulator for enhancing PRP activation in cell therapy workflows.
- Regenovue AQUA SHINE Skin hydration booster for deep moisturizing and skin glow enhancement.
- CENTRIFUGE SERIES Fluid component-layer separator (centrifuge) for processing biological samples in PRP and cell therapy procedures.
- Regenovue PN Skin layer booster containing polynucleotides for skin regeneration and repair.
- PLASMA GEL Device/consumable for creating patient-derived plasma-based autologous dermal fillers.
- NEOME Liquid PCL collagen stimulator for long-lasting skin rejuvenation and collagen induction.
- NEOFILL PLLA collagen stimulator for gradual volume restoration and anti-aging treatments.
- AQUAMATE Mesotherapy injector device for precise intradermal injection of aesthetic solutions.
- LEFIL INJECTOR Mesotherapy injector for controlled delivery of aesthetic compounds into the skin.
- SPOTLESS Skin blemish remover device for treating various skin imperfections.
- EXONOVUE Newly launched NeoGenesis product; details available via PDF catalog download.
Quantifiable outcome
- Exporting to 100+ countries worldwide
- +2 more outcomes
Companies that use NeoGenesis
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
NeoGenesis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
NeoGenesis partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and strategic.
- AKSDERMA (Beauty S LLC)coreAKSDERMA is the exclusive distributor for REGENOVUE HA Dermal Filler Series in Russia. Contact: AKSDERMA +7 915 258-22-25 / [email protected]. Partnership announced September 2025.
- Baby Face AestheticcoreBaby Face Aesthetic is the exclusive distributor for SHAYANA Filler Series in Uzbekistan. Partnership announced September 2025.
- Seyedhedayat YasoubirostamcoreSeyedhedayat Yasoubirostam is the exclusive distributor for SHAYANA products in Iran. Contact: +989120710320 / [email protected].
- KIN AestheticscoreKIN Aesthetics is the exclusive distributor for BETA Serum in USA. Products available through https://esthisupply.com/products/neogenesis-beta-serum.
- Aqua Estetica (Azerbaijan)coreAqua Estetica is the exclusive distributor for Regenovue Glam in Azerbaijan.
- Polymedical (Azerbaijan)corePolymedical is the exclusive distributor for Regenovue PN in Azerbaijan.
- Elisa Tibbi Gerecler Sanayi Limited Sirket (Turkey)coreElisa Tibbi Gerecler Sanayi Limited Sirket is the exclusive distributor for NEOTOX botulinum toxin in Turkey.
- NeoGenesis USA (Overseas Branch)strategicUS branch established November 2014. Signed exclusive distribution contract with local institution for UNISTATION stem cell isolation device.
- NeoGenesis Thailand (Overseas Branch)strategicThailand branch established September 2013. Signed MOU for exclusive distribution of UNISTATION and PRP Series with local institution.
- NeoGenesis China (Overseas Branch)strategicChina branch established May 2013. Expert team established with China warehouse. Manages distribution across Chinese market.
- NeoGenesis Taiwan (Overseas Branch)strategicTaiwan branch established January 2013. Signed MOU for exclusive distribution of UNISTATION with local institution.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
NeoGenesis competitors and assessment
Company assessmentDirect peers
- Benev Company: US/Korean-aligned medical aesthetics company with an injectable and skincare portfolio sold to clinics. Comparable on cross-Pacific aesthetics distribution model.
- Laboratoires Vivacy: French aesthetic medicine company marketing Stylage HA fillers and PDO/PCL lifting threads. Direct peer on REGENOVUE fillers and NEO THREADS category overlap.
- Medytox: Korean company with Medytoxin (botulinum toxin) and a HA filler line, exporting internationally. Closest direct peer given overlap on botulinum toxin and HA filler categories.
- Hugel: Korean aesthetics company marketing Botulax (botulinum toxin) and HA dermal fillers globally. Direct comparable on portfolio mix (toxin + fillers), Korean origin, and export-driven growth model.
- IBSA Pharma: Swiss pharmaceutical company with Profhilo (HA skin booster) and other aesthetic injectable lines. Comparable on premium HA-based aesthetic injectable positioning.
- Jeisys Medical: Korean medical aesthetic device company (Shurink/Ultraformer HIFU devices) with global distribution. Direct comparable on Korean-originated aesthetic device exports across 100+ countries.
- RegenLab: Swiss company specializing in PRP and cell therapy preparation devices used by aesthetic and regenerative medicine clinics. Direct peer for NeoGenesis's PRP kits, CENTRIFUGE series, and cell therapy positioning.
- Croma-Pharma: Austrian aesthetics company offering HA dermal fillers, PDO/PCL threads, and PRP systems. Closely comparable product mix to NeoGenesis's REGENOVUE fillers + NEO THREADS + PRP series.
Broad incumbents
- Galderma: Global aesthetics giant with Restylane fillers, Sculptra (PLLA), and Dysport. Overlaps across NeoGenesis's filler and collagen stimulator product lines at much larger scale.
- AbbVie (Allergan Aesthetics): Markets Botox (botulinum toxin), Juvederm (HA fillers), and CoolSculpting. Competes head-on with NEOTOX and REGENOVUE fillers as the dominant aesthetic incumbent.
Market position
Strengths5 records
Weaknesses6 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
NeoGenesis social profiles
Digital presenceNeoGenesis compliance and trust
Trust signalCompliance2 records
NeoGenesis financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoGenesis leadership team
Management profileNumber of profiles
Profiles1 record
NeoGenesis subsidiaries and ownership
Company hierarchySubsidiaries4 records
NeoGenesis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoGenesis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoGenesis
What does NeoGenesis do?
NeoGenesis Co., Ltd. manufactures and globally distributes autologous cell therapy medical devices (stem cell isolators, centrifuges, PRP kits, plasma gel makers) and aesthetic medical products (HA dermal fillers, botulinum toxin, lifting threads, collagen stimulators, mesotherapy injectors). The company also sells pharmaceutical topical anesthetic creams and post-procedure cosmetic products. Sales are conducted B2B through direct inquiry, four overseas branches, and exclusive regional distributors serving 100+ countries.
Is NeoGenesis a public or private company?
NeoGenesis is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeoGenesis founded?
NeoGenesis was founded in 2012. It employs 11 to 50 people.
Where is NeoGenesis based?
NeoGenesis is headquartered in Seoul, South Korea, in the Asia region.
How does NeoGenesis make money?
Five revenue lines are on record. Medical Device Sales are the primary driver. The others are aesthetic Product Sales, PRP and Cell Therapy Products, pharmaceuticals and cosmetics.
Who are NeoGenesis's main competitors?
Direct peers on record are Benev Company, Laboratoires Vivacy, Medytox, Hugel, IBSA Pharma, Jeisys Medical, RegenLab and Croma-Pharma. Broad incumbents are Galderma and AbbVie (Allergan Aesthetics).
Does NeoGenesis have an API?
No public API is recorded for NeoGenesis.
What industry is NeoGenesis in?
NeoGenesis's product category is Autologous Cell Therapy Medical Devices. Its primary akta.pro industry code is HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables), with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 33911 and its SIC code is 3841.